Anti-inflammatory effect of Moringa oleifera Lam. seeds on acetic acid-induced acute colitis in rats

سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 341

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_AJP-4-2_007

تاریخ نمایه سازی: 1 مهر 1398

چکیده مقاله:

Objective: Anti-inflammatory, immuno-modulatory, and antioxidant properties of Moringa oleifera Lam. suggest that it might have beneficial effects on colitis. The present study was performed to investigate the anticolitis effect of Moringa oleifera seeds hydro-alcoholic extract (MSHE) and its chloroform fraction (MCF) on acetic acid-induced colitis in rats. Materials and Methods: Both MSHE and MCF with three increasing doses (50, 100, and 200 mg/kg) were administered orally to separate groups of male Wistar rats, 2 h before ulcer induction (using acetic acid 4%) and continued for 5 days. Prednisolone (4 mg/kg) and normal saline (1 ml/kg) were used in reference and control groups, respectively. All rats were sacrificed 24 h after the last dose (at day 6) and tissue injuries were assessed macroscopically and pathologically. Results: Extracts with three doses mentioned before were effective to reduce weight of distal colon (8 cm) as a marker for inflammation and tissue edema. Three doses of MSHE and two greater doses of MCF (100 and 200 mg/kg) were effective to reduce ulcer severity, area, and index as well as mucosal inflammation severity and extent, crypt damage, invasion involvement, total colitis index, and MPO activity compared with controls. MCF (50 mg/kg) was not significantly effective in reducing evaluated parameters of colitis compared with controls. Conclusion: It is concluded that MSHE and MCF were both effective to treat experimental colitis and this might be attributed to their similar major components, biophenols and flavonoids. Since the efficacy was evident even in low doses of MSHE, presence of active constituents with high potency in seeds is persuasive.

نویسندگان

Mohsen Minaiyan

Department of Pharmacology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R.Iran.

Gholamreza Asghari

Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I. R. Iran

Diana Taheri

Department of Clinical Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I. R. Iran

Mozhgan Saeidi

Isfahan Pharmaceutical Sciences Research Center, Isfahan, I. R. Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Anwar F, Latif S, Ashraf M, Gilani AH. 2007. Moringa ...
  • Caceres A, Saravia A, Rizzo S, Zabala L, Leon ED, ...
  • Cooper HS, Murthy SNS, Shah RS, Sedergran DJ. 1993. Clinicopathologic ...
  • Dieleman LA, Palmen MJHJ, Akol H, Bloemena E, Pena AS, ...
  • Fahey JW. 2005. Moringa oleifera: A review of the medical ...
  • Ferreira PMP, Farias DF, Oliveira JTA, Carvalho AFU. 2008. Moringa ...
  • Frankel EN, Meyer AS. 2000. The problems of using one-dimensional ...
  • Ghassemi-Dehkordi N. 2002. Matricaria. In: Iranian Herbal Pharmacopoeia Scientific Committee ...
  • Ghia JE, Blennerhassett P, Collins SM. 2007. Vagus nerve integrity ...
  • Gholap PA, Nirmal SA, Pattan SR, Pal SC, Mandal SC. ...
  • Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, ...
  • Koneni VS, Jammikuntla N, Rakesh S, Ram R, Siron MR. ...
  • MacPherson BR, Pfeiffer CJ. 1978. Experimental production of diffuse colitis ...
  • Mahajan SG, Mali RG, Mehta AA. 2007. Effect of Moringa ...
  • Maisuthisakul P, Suttajit M,  Pongsawatmanit R. 2007. Assessment of phenolic ...
  • Matsuda H, Ochi M, Nagatomo A, Yoshikawa M. 2007. Effects ...
  • McQuaid KR. 2007. Drugs used in the treatment of gastrointestinal ...
  • Mehta A, Agrawal B. 2008. Investigation into the mechanism of ...
  • Minaiyan M, Ghassemi-Dehkordi N, Mahzouni P, Ansari-Roknabady M. 2011. Effect ...
  • Minaiyan M, Ghannadi AR, Mahzouni P, Nabi-Meibodi M. 2008. Anti-ulcerogenic ...
  • Minaiyan M, Ghannadi AR, Karimzadeh A. 2006. Antiulcerogenic effects of ...
  • Montoro P, Braca A, Pizza C, De Tommasi N. 2005. ...
  • Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, ...
  • Motavallian A, Minaiyan M, Rabbani M, Mahzuni P. 2012. Anti-inflammatory ...
  • Murata Y, Ishiguru Y, Itoh J, Munakata A, Yoshida Y. ...
  • Podolsky DK. 1991. Inflammatory bowel disease. N Engl J Med, ...
  • Sartor RB. 1997. Pathogenesis and immune mechanism of chronic inflammatory ...
  • Sellin JH, Pasricha PJ. 2006. Pharmacotherapy of inflammatory bowel diseases. ...
  • Shaheen E, Annette K. 2011. Anti-inflammatory effects of nicotine in ...
  • Shaila G, Mahjan, Anita A. 2010. Immunosuppresive activity of ethanolic ...
  • Siddhuraju P, Becker K. 2003. Antioxidant properties of various solvent ...
  • Verma AR,Vijayakumar M, Mathela CS, Rao CV. 2009. In vitro ...
  • نمایش کامل مراجع